SLICE-CEA CardioLink-8: A Randomized Trial of Evolocumab on Carotid Artery Atherosclerotic Plaque Characteristics in Asymptomatic High-Risk Carotid Stenosis.

MLA

Mazer, C.David, et al. “SLICE-CEA CardioLink-8: A Randomized Trial of Evolocumab on Carotid Artery Atherosclerotic Plaque Characteristics in Asymptomatic High-Risk Carotid Stenosis.” Circulation, vol. 151, no. 4, Jan. 2025, pp. 351–55. EBSCOhost, https://doi.org/10.1161/CIRCULATIONAHA.124.072285.

APA

Mazer, C. D., Moody, A. R., Teoh, H., Quan, A., Elituv, R., Vivekanandan, T., Li, P., Thorpe, K. E., Lafreniere-Roula, M., Verma, R., Moroney, M., Casey, J. H., Singh, N., Bharatha, A., Mahmoud, R., Manorajah, R., Jayarajah, A., Kapadia, A. N., Dueck, A. D., & Al-Omran, M. (2025). SLICE-CEA CardioLink-8: A Randomized Trial of Evolocumab on Carotid Artery Atherosclerotic Plaque Characteristics in Asymptomatic High-Risk Carotid Stenosis. Circulation, 151(4), 351–355. https://doi.org/10.1161/CIRCULATIONAHA.124.072285

Chicago

Mazer, C. David, Alan R. Moody, Hwee Teoh, Adrian Quan, Randi Elituv, Thayalasuthan Vivekanandan, Peiyu Li, et al. 2025. “SLICE-CEA CardioLink-8: A Randomized Trial of Evolocumab on Carotid Artery Atherosclerotic Plaque Characteristics in Asymptomatic High-Risk Carotid Stenosis.” Circulation 151 (4): 351–55. doi:10.1161/CIRCULATIONAHA.124.072285.